The cellular oncogenes and tumor suppressor genes are analogous to the accelerator and brake pedals in a car. If an oncogene is permanently active, similar to a stuck accelerator in a car, cells divide without restraints and a tumor develops.
The c-MYC proto-oncogene is activated aberrantly in about 50% of all tumors. As a result the c-MYC protein is produced in excessive amounts, which in turn activates processes associated with cell proliferation. A group of research scientists led by Prof. Heiko Hermeking (Institute of Pathology, Ruhr-University Bochum, Germany) has now identified a mechanism that allows c-MYC to drive cellular proliferation in the presence of substances that would lead to a block in cell division in normal cells, as for example chemotherapeutic agents.
“In future this knowledge may allow a more specific inhibition of tumor growth” Hermeking hopes. This study has been published in the current edition of the Proceedings of the National Academy of Sciences USA (PNAS).
Attractive target structure for cancer drugs
The c-MYC gene is a nodal point in the regulation of cellular division and is highly expressed in colorectal cancer and many other tumor types. The c-MYC protein is a transcription factor which regulates other genes, which in turn mediate the effects of c-MYC on cell proliferation. “In order to understand the origin of cancer it is therefore important to identify genes and mechanisms that mediate the effects of c-MYC on cells” Prof. Hermeking explained. Because of its central position in the regulation of cell proliferation c-MYC is an attractive target structure for cancer therapeutic agents.
Signaling chain unraveled in detail
Prof. Hermeking’s research team determined how c-MYC promotes proliferation. They were able to demonstrate that c-MYC activates the AP4 gene, which results in the synthesis of AP4 protein. AP4 protein in turn suppresses the formation of a central inhibitor of cellular division (p21) by occupying its regulatory region within the genome. Thereby tumor cells become refractory to substances, e.g. chemotherapeutic agents, which block cell division in normal cells.
Instead of terminating proliferation the tumor cells undergo cell death. Moreover, the scientists discovered that colorectal carcinomas, in contrast to normal colon tissue, generally produce large amounts of the AP4 protein. In the future, the knowledge about this signaling cascade could enable a more targeted prevention of cancer cell proliferation. The project is supported by the German Cancer Aid (Deutsche Krebshilfe e.V.).
Prof. Dr. Heiko Hermeking | alfa
More genes are active in high-performance maize
19.01.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn
How plants see light
19.01.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau
On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.
We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...
What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...
For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.
Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...
At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.
No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...
Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.
Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
19.01.2018 | Materials Sciences
19.01.2018 | Health and Medicine
19.01.2018 | Physics and Astronomy